Tuesday, April 22, 2008

NanoNewsCustom 4/22/08

WebmailSkip to Main Content | Skip to Webmail Actions | Skip to Mailbox Navigation
User Options
Comcast.netHelpSign Out
Actions
Get email
Get emailCompose
ComposeVideomail
VideomailReplyReply allForwardPrintReport as spamDeleteEmail Storage[view details] Search
Search Mail Mailbox: ftcua8@comcast.net INBOX: Email 24 of 4900 Move to Folder INBOX Draft Screened Mail SentMail Trash Drafts < Previous | Next >
Read Message
From:"NanoNews Custom"
[Add to Address Book]

To:ftcua8@comcast.net
Subject:Nanotechnology Now - NanoNews Custom
Date:Tuesday, April 22, 2008 11:00:32 AM
[View Source]

There have been 22 news stories since your last update.

Academic/Education

Undergraduate students awarded NSF Research Fellowships
thetartan.org April 22, 2008 The human body contains only one enantiomer of each pair for most compounds. If the wrong enantiomer enters the human body, the results can be fatal. Many pharmaceutical drugs contain both enantiomers, which have to be separated before humans can take the drugs. Bartel is using nanotechnology to develop a fast and efficient technique for the separation process. Recently, Bartel proved that gold nanoparticles coated with the amino acid cysteine were capable of separating a mixture of propylene oxide enantiomers. Bartel intends to incorporate nanotechnology into biology and medicine. She has been accepted into the Ph.D. program at the University of California, Berkeley, and plans to continue her research there next fall.


Nanotechnology inspires L.A. youth
UCLA April 22, 2008 Liz De La Torre plans to study medicine and become a doctor someday. A junior at John Marshall High School, De La Torre was one of more than 150 Los Angeles-area high school students who attended the California NanoSystems Institute's High School Day, held Saturday at UCLA. Organizers sought to inspire students to pursue studies in nanoscience, or "the science of small things," as well as the sciences in general, said Sarah Tolbert, director of the institute's outreach program.


Monash plans $45m nanotech operation
australianit.news.com.au April 21, 2008 MONASH University has signed an agreement with the Australian National Fabrication Facility to develop a $45 million purpose-built nanotech operation by late 2009. The Melbourne Centre for Nanofabrication, to be developed next to Monash's Clayton campus, will be the Victorian node of the national network, designed to boost Australia's presence in nano and bio-nanotechnological markets. Monash is the lead agency for the project, a collaboration between state and federal governments, the CSIRO and several Victorian universities. The centre will offer a wide range of services for the development and manufacture of prototypes and products from a broad disciplinary base, including bio-compatible materials for smarter medical implants, water recycling systems to improve re-use of urban water, rapid and disposable diagnostic tests to improve the detection and response to infectious diseases and energy storage and generation technology to enable breakthroughs such as using roof tiles as cheap solar cells.


NIST Signs Cooperative Agreement with U-Albany Nano College
NIST April 21, 2008 The Commerce Department's National Institute of Standards and Technology (NIST) signed a Memorandum of Understanding (MOU) today with the College of Nanoscale Science and Engineering (CNSE) of the University at Albany-State University of New York. NIST Deputy Director James M. Turner, CNSE Vice President and Chief Administrative Officer Alain E. Kaloyeros and Senator Charles E. Schumer (D-N.Y.) participated in an Albany signing ceremony hosted by Senator Schumer. The event was held at CNSE's Albany NanoTech Complex, a $4.2 billion, 450,000 square-foot facility which houses more than 2,000 employees including many from the semiconductor industry.


TU/e starts Institute for Complex Molecular Systems
Eindhoven University of Technology April 21, 2008 Researchers from a wide range of disciplines at Eindhoven University of Technology (TU/e) will be joining forces in the Institute for Complex Molecular Systems (ICMS). They will be investigating the exact mechanism behind self-organization, the principle behind all life on earth. Researchers plan to use this knowledge to build molecular mini-factories that could produce the next generation of catalysts, photosynthetic systems, nanocontainers and functional materials. Prof. Bert Meijer will head the institute. The Executive Board of the university decided last week to allocate 15 million euros to the institute over the next 10 years.


Announcements

Undergraduate students awarded NSF Research Fellowships
thetartan.org April 22, 2008 The human body contains only one enantiomer of each pair for most compounds. If the wrong enantiomer enters the human body, the results can be fatal. Many pharmaceutical drugs contain both enantiomers, which have to be separated before humans can take the drugs. Bartel is using nanotechnology to develop a fast and efficient technique for the separation process. Recently, Bartel proved that gold nanoparticles coated with the amino acid cysteine were capable of separating a mixture of propylene oxide enantiomers. Bartel intends to incorporate nanotechnology into biology and medicine. She has been accepted into the Ph.D. program at the University of California, Berkeley, and plans to continue her research there next fall.


Tiny Technology To Revolutionise Hotel Rooms Nanotechnology And Sustainability Under The Spotlight At The Hotel Show Seven Star Conference
The Hotel Show Seven Star Conference April 22, 2008 Pillows that glow in the dark and "smart" sheets that read a guest's body heat are among futuristic products set to revolutionise the hospitality business, according to a leading industry expert.


Renesas collaborates with IMEC on reconfigurable RF transceivers
Renesas Technology Corp. April 22, 2008 Renesas Technology Corp., one of the world's leading semiconductor system solutions providers for mobile, automotive and PC/AV (Audio Visual) markets, has entered into a strategic research collaboration with IMEC, Europe's leading independent research center in the field of nanoelectronics, to perform research on 45nm RF transceivers targeting Gbit/s cognitive radios. To this end, Renesas has joined IMEC's software-defined radio (SDR) front-end program. This research program includes reconfigurable RF solutions, high-speed/low-power analog-to-digital converters (ADCs) and new approaches to digitize future RF architectures.


Media Advisory: Carl Zeiss SMT Celebrates Grand Opening of New North American Headquarters
Carl Zeiss SMT Inc. April 21, 2008 Who: Carl Zeiss SMT Inc. What: Opens New North American Headquarters When: Wednesday, April 23, 2008, 11:00 a.m. - approx. 2:00 p.m. Where: One Corporation Way, Peabody, MA 01960 Why: Learn how the invention of a revolutionary new microscope by a small startup company in Peabody caused a billion dollar division of a world renowned German company to locate its North American headquarters in Massachusetts.


4th Floor Investments Completes Sale of SmalTec International LLC
4th Floor Investment Group, LLC April 21, 2008 Microtechnology Manufacturing Company Generated Significant Returns For 4th Floor Investments During Its 6-Year Investment


Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic
Calando Pharmaceuticals April 21, 2008 FDA Approval to Proceed with Proprietary RONDEL™ Drug Delivery System and siRNA Combined for First Targeted, Systemic Delivery in Oncology Phase I Clinical Trial


Annual General Meeting of neosino nano­technologies AG Decides to Rename Company adinotec AG
neosino nanotechnologies AG April 21, 2008 At the neosino nanotechnologies AG AGM held 18. April in Griesheim, shareholders decided to rename the company adinotec AG.


Nanobiosym CEO Dr. Anita Goel to Testify in US Senate: ''Harnessing Nanotechnology to Drive the New Global Economy''
Nanobiosym Inc. April 21, 2008 Nanobiosym Chairman & CEO Dr. Anita Goel, MD, PhD, will present a fresh new vision for American leadership in the coming global nanotechnology revolution to the Senate Subcommittee on Science, Technology and Innovation, chaired by Senator John Kerry (D-Mass.). Dr. Goel, an internationally recognized nanotech expert and a Harvard-MIT trained physicist and physician, will provide testimony at the US Senate hearing on reauthorizing the billion plus-dollar National Nanotechnology Initiative (NNI).


Starpharma Holdings (ASX:SPL) Studies Show That VivaGel Inhibits Clinically Relevant Strains Of Human Papillomavirus (HPV) In Laboratory Tests
Starpharma Holdings Ltd April 21, 2008 Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced that recent studies have shown that SPL7013, the active ingredient in its topical microbicide VivaGel(R), inhibits clinically-relevant strains of the human papillomavirus (HPV) in laboratory tests.


Monash plans $45m nanotech operation
australianit.news.com.au April 21, 2008 MONASH University has signed an agreement with the Australian National Fabrication Facility to develop a $45 million purpose-built nanotech operation by late 2009. The Melbourne Centre for Nanofabrication, to be developed next to Monash's Clayton campus, will be the Victorian node of the national network, designed to boost Australia's presence in nano and bio-nanotechnological markets. Monash is the lead agency for the project, a collaboration between state and federal governments, the CSIRO and several Victorian universities. The centre will offer a wide range of services for the development and manufacture of prototypes and products from a broad disciplinary base, including bio-compatible materials for smarter medical implants, water recycling systems to improve re-use of urban water, rapid and disposable diagnostic tests to improve the detection and response to infectious diseases and energy storage and generation technology to enable breakthroughs such as using roof tiles as cheap solar cells.


Europe Spends Nearly Twice as Much as US on Nanotech Risk Research
Project on Emerging Nanotechnologies April 21, 2008 Assessment of 2006 Funding Shows U.S. Lags in Highly Relevant Nano Risk Research


Starpharma Holdings (ASX:SPL) Announce Commercial Product Launch Of Priostar(R) Dendrimer Technology As NanoJuiceTM
Starpharma Holdings Ltd April 21, 2008 Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced the first commercial product launch based on its Priostar(R) dendrimer technology.


A Round of Applause for the Gonorrhea-Based Molecular Machine
gizmodo.com.au April 21, 2008 Gonorrhea isn't just an STD known for causing burning sensations when you pee; it's the strongest organism known to man. Able to pull 100,000 times its body weight, the clap may soon serve a purpose greater than painfully reminding you of nights spent cruising the Red Light District. Scientists hope to use gonorrhea bacteria in nanotech devices because of the strong forces they can exert on nearby objects. In the clip above, gonorrhea is using pili filaments it produces, which are 10 times longer than the bacterium itself, to pull tiny columns.


Mattson Technology Selected as Development Partner by Leading Global Semiconductor Manufacturer For Advanced Millisecond Anneal Processing
Mattson Technology, Inc. April 21, 2008 Millios(TM) Flash RTP System Enables Advanced 45 nm and Beyond Processes


Picosun and Tohoku University announce their co-operation in Atomic Layer Deposition
Picosun Oy April 21, 2008 Picosun Oy, Finland and Tohoku University, Japan announce their collaboration in the field of Atomic Layer Deposition (ALD).


SEMATECH Researchers Demonstrate High-k Metal Gates for 22 nm Node and Advancements Resulting in Practical FinFETs and High Mobility Ge Channels
SEMATECH April 21, 2008 SEMATECH researchers are presenting trend-setting research results in extending CMOS logic and memory technologies at the International Symposium on VLSI Technology, System and Applications (VLSI-TSA) this week. The new materials, processes and concepts discussed in a series of seven research papers describe how current semiconductor technologies can benefit from performance-enhancing features for future scaling needs.


NIST Signs Cooperative Agreement with U-Albany Nano College
NIST April 21, 2008 The Commerce Department's National Institute of Standards and Technology (NIST) signed a Memorandum of Understanding (MOU) today with the College of Nanoscale Science and Engineering (CNSE) of the University at Albany-State University of New York. NIST Deputy Director James M. Turner, CNSE Vice President and Chief Administrative Officer Alain E. Kaloyeros and Senator Charles E. Schumer (D-N.Y.) participated in an Albany signing ceremony hosted by Senator Schumer. The event was held at CNSE's Albany NanoTech Complex, a $4.2 billion, 450,000 square-foot facility which houses more than 2,000 employees including many from the semiconductor industry.


TU/e starts Institute for Complex Molecular Systems
Eindhoven University of Technology April 21, 2008 Researchers from a wide range of disciplines at Eindhoven University of Technology (TU/e) will be joining forces in the Institute for Complex Molecular Systems (ICMS). They will be investigating the exact mechanism behind self-organization, the principle behind all life on earth. Researchers plan to use this knowledge to build molecular mini-factories that could produce the next generation of catalysts, photosynthetic systems, nanocontainers and functional materials. Prof. Bert Meijer will head the institute. The Executive Board of the university decided last week to allocate 15 million euros to the institute over the next 10 years.


Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and
Charlesson LLC April 21, 2008 Company aims to develop novel therapies to prevent blindness


Professor explores nanotech for cancer
indianewengland.com April 21, 2008 Mansoor Amiji is working on finding a way to deliver drugs to cancer patients using nanomedicine. Amiji, 44, an associate department chairman in the Pharmaceutical Sciences Department at Northeastern University's School of Pharmacy, is involved with a research group funded by the National Institutes of Health and the National Cancer Institute for the project, which involves the combination of nanotechnology and medicine to treat cancer patients. Nanomedicine treats diseases, like cancer, at the molecular level, said Amiji. Such technology could be used as a way to target the sick part of a person's body, delivering medicine to the diseased area without harming the rest of the body, he said. In nanomedicine, drugs are delivered to cancer cells through nanoparticles, which are so small that they are able to penetrate through to the protein and DNA inside of the cells of diseased tissues. They are designed to carry anti-cancer drugs and bring that medication all the way to the diseased cells in a person's body without harming the healthy cells.


Brown Chemist Finds Platinum Nanocube Enhances Fuel Cell Operation
Brown University April 21, 2008 A team of chemists at Brown University for the first time has consistently created uniform platinum nanocubes, a breakthrough that could make hydrogen fuel cells more efficient and less costly.


Automotive/Transportation

Renesas collaborates with IMEC on reconfigurable RF transceivers
Renesas Technology Corp. April 22, 2008 Renesas Technology Corp., one of the world's leading semiconductor system solutions providers for mobile, automotive and PC/AV (Audio Visual) markets, has entered into a strategic research collaboration with IMEC, Europe's leading independent research center in the field of nanoelectronics, to perform research on 45nm RF transceivers targeting Gbit/s cognitive radios. To this end, Renesas has joined IMEC's software-defined radio (SDR) front-end program. This research program includes reconfigurable RF solutions, high-speed/low-power analog-to-digital converters (ADCs) and new approaches to digitize future RF architectures.


Chip Technology

Renesas collaborates with IMEC on reconfigurable RF transceivers
Renesas Technology Corp. April 22, 2008 Renesas Technology Corp., one of the world's leading semiconductor system solutions providers for mobile, automotive and PC/AV (Audio Visual) markets, has entered into a strategic research collaboration with IMEC, Europe's leading independent research center in the field of nanoelectronics, to perform research on 45nm RF transceivers targeting Gbit/s cognitive radios. To this end, Renesas has joined IMEC's software-defined radio (SDR) front-end program. This research program includes reconfigurable RF solutions, high-speed/low-power analog-to-digital converters (ADCs) and new approaches to digitize future RF architectures.


Mattson Technology Selected as Development Partner by Leading Global Semiconductor Manufacturer For Advanced Millisecond Anneal Processing
Mattson Technology, Inc. April 21, 2008 Millios(TM) Flash RTP System Enables Advanced 45 nm and Beyond Processes


Picosun and Tohoku University announce their co-operation in Atomic Layer Deposition
Picosun Oy April 21, 2008 Picosun Oy, Finland and Tohoku University, Japan announce their collaboration in the field of Atomic Layer Deposition (ALD).


SEMATECH Researchers Demonstrate High-k Metal Gates for 22 nm Node and Advancements Resulting in Practical FinFETs and High Mobility Ge Channels
SEMATECH April 21, 2008 SEMATECH researchers are presenting trend-setting research results in extending CMOS logic and memory technologies at the International Symposium on VLSI Technology, System and Applications (VLSI-TSA) this week. The new materials, processes and concepts discussed in a series of seven research papers describe how current semiconductor technologies can benefit from performance-enhancing features for future scaling needs.


Energy

Brown Chemist Finds Platinum Nanocube Enhances Fuel Cell Operation
Brown University April 21, 2008 A team of chemists at Brown University for the first time has consistently created uniform platinum nanocubes, a breakthrough that could make hydrogen fuel cells more efficient and less costly.


Govt.-Legislation/Regulation/Funding/Policy

Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic
Calando Pharmaceuticals April 21, 2008 FDA Approval to Proceed with Proprietary RONDEL™ Drug Delivery System and siRNA Combined for First Targeted, Systemic Delivery in Oncology Phase I Clinical Trial


Nanobiosym CEO Dr. Anita Goel to Testify in US Senate: ''Harnessing Nanotechnology to Drive the New Global Economy''
Nanobiosym Inc. April 21, 2008 Nanobiosym Chairman & CEO Dr. Anita Goel, MD, PhD, will present a fresh new vision for American leadership in the coming global nanotechnology revolution to the Senate Subcommittee on Science, Technology and Innovation, chaired by Senator John Kerry (D-Mass.). Dr. Goel, an internationally recognized nanotech expert and a Harvard-MIT trained physicist and physician, will provide testimony at the US Senate hearing on reauthorizing the billion plus-dollar National Nanotechnology Initiative (NNI).


Europe Spends Nearly Twice as Much as US on Nanotech Risk Research
Project on Emerging Nanotechnologies April 21, 2008 Assessment of 2006 Funding Shows U.S. Lags in Highly Relevant Nano Risk Research


Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and
Charlesson LLC April 21, 2008 Company aims to develop novel therapies to prevent blindness


Interviews/Book Reviews/Essays/Reports/Podcasts

Nanotechnology inspires L.A. youth
UCLA April 22, 2008 Liz De La Torre plans to study medicine and become a doctor someday. A junior at John Marshall High School, De La Torre was one of more than 150 Los Angeles-area high school students who attended the California NanoSystems Institute's High School Day, held Saturday at UCLA. Organizers sought to inspire students to pursue studies in nanoscience, or "the science of small things," as well as the sciences in general, said Sarah Tolbert, director of the institute's outreach program.


Investments/IPO's/Splits

4th Floor Investments Completes Sale of SmalTec International LLC
4th Floor Investment Group, LLC April 21, 2008 Microtechnology Manufacturing Company Generated Significant Returns For 4th Floor Investments During Its 6-Year Investment


Molecular Machines

A Round of Applause for the Gonorrhea-Based Molecular Machine
gizmodo.com.au April 21, 2008 Gonorrhea isn't just an STD known for causing burning sensations when you pee; it's the strongest organism known to man. Able to pull 100,000 times its body weight, the clap may soon serve a purpose greater than painfully reminding you of nights spent cruising the Red Light District. Scientists hope to use gonorrhea bacteria in nanotech devices because of the strong forces they can exert on nearby objects. In the clip above, gonorrhea is using pili filaments it produces, which are 10 times longer than the bacterium itself, to pull tiny columns.


Molecular Nanotechnology

TU/e starts Institute for Complex Molecular Systems
Eindhoven University of Technology April 21, 2008 Researchers from a wide range of disciplines at Eindhoven University of Technology (TU/e) will be joining forces in the Institute for Complex Molecular Systems (ICMS). They will be investigating the exact mechanism behind self-organization, the principle behind all life on earth. Researchers plan to use this knowledge to build molecular mini-factories that could produce the next generation of catalysts, photosynthetic systems, nanocontainers and functional materials. Prof. Bert Meijer will head the institute. The Executive Board of the university decided last week to allocate 15 million euros to the institute over the next 10 years.


Nanoelectronics

Renesas collaborates with IMEC on reconfigurable RF transceivers
Renesas Technology Corp. April 22, 2008 Renesas Technology Corp., one of the world's leading semiconductor system solutions providers for mobile, automotive and PC/AV (Audio Visual) markets, has entered into a strategic research collaboration with IMEC, Europe's leading independent research center in the field of nanoelectronics, to perform research on 45nm RF transceivers targeting Gbit/s cognitive radios. To this end, Renesas has joined IMEC's software-defined radio (SDR) front-end program. This research program includes reconfigurable RF solutions, high-speed/low-power analog-to-digital converters (ADCs) and new approaches to digitize future RF architectures.


SEMATECH Researchers Demonstrate High-k Metal Gates for 22 nm Node and Advancements Resulting in Practical FinFETs and High Mobility Ge Channels
SEMATECH April 21, 2008 SEMATECH researchers are presenting trend-setting research results in extending CMOS logic and memory technologies at the International Symposium on VLSI Technology, System and Applications (VLSI-TSA) this week. The new materials, processes and concepts discussed in a series of seven research papers describe how current semiconductor technologies can benefit from performance-enhancing features for future scaling needs.


Nanomedicine

Undergraduate students awarded NSF Research Fellowships
thetartan.org April 22, 2008 The human body contains only one enantiomer of each pair for most compounds. If the wrong enantiomer enters the human body, the results can be fatal. Many pharmaceutical drugs contain both enantiomers, which have to be separated before humans can take the drugs. Bartel is using nanotechnology to develop a fast and efficient technique for the separation process. Recently, Bartel proved that gold nanoparticles coated with the amino acid cysteine were capable of separating a mixture of propylene oxide enantiomers. Bartel intends to incorporate nanotechnology into biology and medicine. She has been accepted into the Ph.D. program at the University of California, Berkeley, and plans to continue her research there next fall.


Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic
Calando Pharmaceuticals April 21, 2008 FDA Approval to Proceed with Proprietary RONDEL™ Drug Delivery System and siRNA Combined for First Targeted, Systemic Delivery in Oncology Phase I Clinical Trial


Starpharma Holdings (ASX:SPL) Studies Show That VivaGel Inhibits Clinically Relevant Strains Of Human Papillomavirus (HPV) In Laboratory Tests
Starpharma Holdings Ltd April 21, 2008 Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced that recent studies have shown that SPL7013, the active ingredient in its topical microbicide VivaGel(R), inhibits clinically-relevant strains of the human papillomavirus (HPV) in laboratory tests.


Starpharma Holdings (ASX:SPL) Announce Commercial Product Launch Of Priostar(R) Dendrimer Technology As NanoJuiceTM
Starpharma Holdings Ltd April 21, 2008 Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced the first commercial product launch based on its Priostar(R) dendrimer technology.


A Round of Applause for the Gonorrhea-Based Molecular Machine
gizmodo.com.au April 21, 2008 Gonorrhea isn't just an STD known for causing burning sensations when you pee; it's the strongest organism known to man. Able to pull 100,000 times its body weight, the clap may soon serve a purpose greater than painfully reminding you of nights spent cruising the Red Light District. Scientists hope to use gonorrhea bacteria in nanotech devices because of the strong forces they can exert on nearby objects. In the clip above, gonorrhea is using pili filaments it produces, which are 10 times longer than the bacterium itself, to pull tiny columns.


Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and
Charlesson LLC April 21, 2008 Company aims to develop novel therapies to prevent blindness


Professor explores nanotech for cancer
indianewengland.com April 21, 2008 Mansoor Amiji is working on finding a way to deliver drugs to cancer patients using nanomedicine. Amiji, 44, an associate department chairman in the Pharmaceutical Sciences Department at Northeastern University's School of Pharmacy, is involved with a research group funded by the National Institutes of Health and the National Cancer Institute for the project, which involves the combination of nanotechnology and medicine to treat cancer patients. Nanomedicine treats diseases, like cancer, at the molecular level, said Amiji. Such technology could be used as a way to target the sick part of a person's body, delivering medicine to the diseased area without harming the rest of the body, he said. In nanomedicine, drugs are delivered to cancer cells through nanoparticles, which are so small that they are able to penetrate through to the protein and DNA inside of the cells of diseased tissues. They are designed to carry anti-cancer drugs and bring that medication all the way to the diseased cells in a person's body without harming the healthy cells.


Possible Futures

Tiny Technology To Revolutionise Hotel Rooms Nanotechnology And Sustainability Under The Spotlight At The Hotel Show Seven Star Conference
The Hotel Show Seven Star Conference April 22, 2008 Pillows that glow in the dark and "smart" sheets that read a guest's body heat are among futuristic products set to revolutionise the hospitality business, according to a leading industry expert.


Products

Starpharma Holdings (ASX:SPL) Announce Commercial Product Launch Of Priostar(R) Dendrimer Technology As NanoJuiceTM
Starpharma Holdings Ltd April 21, 2008 Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced the first commercial product launch based on its Priostar(R) dendrimer technology.


Safety-Nanoparticles/Risk management

Europe Spends Nearly Twice as Much as US on Nanotech Risk Research
Project on Emerging Nanotechnologies April 21, 2008 Assessment of 2006 Funding Shows U.S. Lags in Highly Relevant Nano Risk Research


Self Assembly

TU/e starts Institute for Complex Molecular Systems
Eindhoven University of Technology April 21, 2008 Researchers from a wide range of disciplines at Eindhoven University of Technology (TU/e) will be joining forces in the Institute for Complex Molecular Systems (ICMS). They will be investigating the exact mechanism behind self-organization, the principle behind all life on earth. Researchers plan to use this knowledge to build molecular mini-factories that could produce the next generation of catalysts, photosynthetic systems, nanocontainers and functional materials. Prof. Bert Meijer will head the institute. The Executive Board of the university decided last week to allocate 15 million euros to the institute over the next 10 years.


Spintronics

Picosun and Tohoku University announce their co-operation in Atomic Layer Deposition
Picosun Oy April 21, 2008 Picosun Oy, Finland and Tohoku University, Japan announce their collaboration in the field of Atomic Layer Deposition (ALD).


Tools

Media Advisory: Carl Zeiss SMT Celebrates Grand Opening of New North American Headquarters
Carl Zeiss SMT Inc. April 21, 2008 Who: Carl Zeiss SMT Inc. What: Opens New North American Headquarters When: Wednesday, April 23, 2008, 11:00 a.m. - approx. 2:00 p.m. Where: One Corporation Way, Peabody, MA 01960 Why: Learn how the invention of a revolutionary new microscope by a small startup company in Peabody caused a billion dollar division of a world renowned German company to locate its North American headquarters in Massachusetts.


4th Floor Investments Completes Sale of SmalTec International LLC
4th Floor Investment Group, LLC April 21, 2008 Microtechnology Manufacturing Company Generated Significant Returns For 4th Floor Investments During Its 6-Year Investment


Mattson Technology Selected as Development Partner by Leading Global Semiconductor Manufacturer For Advanced Millisecond Anneal Processing
Mattson Technology, Inc. April 21, 2008 Millios(TM) Flash RTP System Enables Advanced 45 nm and Beyond Processes


Picosun and Tohoku University announce their co-operation in Atomic Layer Deposition
Picosun Oy April 21, 2008 Picosun Oy, Finland and Tohoku University, Japan announce their collaboration in the field of Atomic Layer Deposition (ALD).


NIST Signs Cooperative Agreement with U-Albany Nano College
NIST April 21, 2008 The Commerce Department's National Institute of Standards and Technology (NIST) signed a Memorandum of Understanding (MOU) today with the College of Nanoscale Science and Engineering (CNSE) of the University at Albany-State University of New York. NIST Deputy Director James M. Turner, CNSE Vice President and Chief Administrative Officer Alain E. Kaloyeros and Senator Charles E. Schumer (D-N.Y.) participated in an Albany signing ceremony hosted by Senator Schumer. The event was held at CNSE's Albany NanoTech Complex, a $4.2 billion, 450,000 square-foot facility which houses more than 2,000 employees including many from the semiconductor industry.


Update your subscription preferences to add additional categories or change your delivery frequency: http://www.nanotech-now.com/products/nanonewscustom/


INBOX: Email 24 of 4900 Move to Folder INBOX Draft Screened Mail SentMail Trash Drafts Back to Top | < Previous | Next > Navigation
Message CenterINBOX 95Draft Screened Mail SentMail Trash
[empty]My Folders
[edit]DraftsAddress BookMailbox ManagerPreferencesVoice MailAdd Comcast ServicesDigital CableDigital Video RecorderDigital Voice®High Definition TV
Ask ComcastWhat's NewIdeas and SuggestionsComcast.net
© 2008 Comcast Cable Communications, LLC. All rights reserved. Privacy Statement Terms of Service

Comcast.net

No comments: